Aviceda
formerly Aviceda TherapeuticsAviceda Therapeutics
Cambridge, United States · Founded 2018 · $572.6M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- avicedarx.com
- Total Funding
- $572.6M
- Last Round
- $300.0M Series BJan 2025
- Rounds
- 4
About
Aviceda Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, pioneering the field of glyco-immune checkpoint therapeutics. The company's proprietary HALOS platform harnesses glycobiology to modulate innate immune pathways — targeting chronic, non-resolving inflammation in ocular and systemic diseases. Its lead asset, AVD-104, is in a Phase 2b/3 clinical trial for Geographic Atrophy (a leading cause of blindness). Aviceda's pipeline addresses macular degeneration, uveitis, retinal degenerative diseases, and autoimmune conditions, combining nanoparticle technology with high-throughput ligand screening to create disease-modifying medicines.
Summary
Aviceda is a Biotech company based in Cambridge, United States, founded in 2018. It has raised $572.6M in total across 4 rounds, most recently a $300.0M Series B round in Jan 2025. Investors include Omega Funds, TCGX and TCG Crossover.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2025
Sign up to see all 4 rounds
Series B through Series C — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aviceda"><img src="https://indexed.vc/api/badge/company/aviceda" alt="Aviceda on Indexed.vc" width="260" height="76" /></a>